Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Salinger, Ari
Bristol-Myers Squibb Company
(
M1030-02-08
)
Simplifying Cellular Immunogenicity Monitoring for Novel Therapeutics through a sMHC-1 Immunopeptidomics Approach
Ari Salinger
Favorite
Samareh Afsari, Hamid
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Hamid Samareh Afsari
Favorite
San Emeterio, Josue
Xenocs, Inc.
(
T0930-01-01
)
Lipid Nanoparticle Morphology and Phase Transitions Investigated through Small Angle X-Ray Scattering and Contrast Variation in a Laboratory Instrument
Josue San Emeterio
Favorite
Sarsarshahi, Sina
University of Iowa
(
M1030-01-04
)
Impact of Handling and Transfer on Aggregation of a Trastuzumab Biosimilar in an In-Use Study
Sina Sarsarshahi
Favorite
Schlender, Jan-Frederik
Novartis
(
T1230-02-08
)
Reverse Translational Modeling for Early Benchmarking of Clinically Active Doses from In Vitro Cell Killing and T-Cell Activation Data for BCMAxCD3 T-Cell Engagers
Jan-Frederik Schlender
Favorite
Schmidt, Marcel
Chimera Biotec GmbH
(
M1230-02-07
)
Development and Validation of a High-Sensitivity PK Assay for CLN-978 Supporting a First in Human Study in Systemic Lupus Erythematosus Using Quanterix SIMOA Technology
Marcel Schmidt
Favorite
Schrass, Leah
University of Kentucky
(
M0930-02-06
)
Investigations into the Effects of Protein Corona Formation on Novel Polymeric Nanoparticle Systems
Leah Schrass
Favorite
Sekar, Ram Prasad
Colorado School of Mines
(
T0930-02-09
)
Polyplex Particle Size Alters Transgene Expression and Cell Viability in a Cell Type-Dependent Manner
Ram Prasad Sekar
Favorite
Sekhoacha, Mamello
University of the Free State
(
M1430-01-01
)
Nanocapsules for Combined Delivery of Docetaxel and
Laguncularia Racemosa
Extract Against Oral Cancer Cells In Vitro
Mamello Sekhoacha
Favorite
Serre, Christian
Institut des Matériaux Poreux de Paris
(
M0930-01-02
)
Exploring the Impact of Iron Availability on Morphology and Antibiotic Resistance in
Mycobacterium
Species
Christian Serre
Favorite
Shao, Hongguang
Frontage Laboratories, Inc.
(
M1230-02-07
)
Development and Validation of a High-Sensitivity PK Assay for CLN-978 Supporting a First in Human Study in Systemic Lupus Erythematosus Using Quanterix SIMOA Technology
Hongguang Shao
Favorite
Shapiro, Irina
Cullinan Therapeutics
(
M1230-02-07
)
Development and Validation of a High-Sensitivity PK Assay for CLN-978 Supporting a First in Human Study in Systemic Lupus Erythematosus Using Quanterix SIMOA Technology
Irina Shapiro
Favorite
Sharma, Puja
Teva Pharmaceutical Industries Ltd.
(
T1030-01-03
)
ATR-FTIR Spectroscopy as an Orthogonal Method for Secondary Structure Characterization of Monoclonal Antibodies Under Thermal Stress
Puja Sharma
Favorite
Shearer, Todd
Cullinan Therapeutics
(
M1230-02-07
)
Development and Validation of a High-Sensitivity PK Assay for CLN-978 Supporting a First in Human Study in Systemic Lupus Erythematosus Using Quanterix SIMOA Technology
Todd Shearer
Favorite
Sheng, Xinyi
Georgia Institute of Technology
(
T1330-01-02
)
Optimizing Gel Network Architecture for Oxanorbornadiene-Based Degradable Hydrogels
Xinyi Sheng
Favorite
Shin, Young G.
ChungNam National University
(
M0930-02-09
)
Comprehensive Pharmacokinetic Profiling of C004019: A PROTAC Targeting Tau Protein in Neurodegenerative Disorders
Young G. Shin
Favorite
(
M1230-02-06
)
Application of icIEF-UV/MS for Rapid Proteoform Characterization and Charge Variant Analysis of a Novel Antibody-Drug Conjugate in Drug Discovery
Young G. Shin
Favorite
(
M1430-02-07
)
Assessment of Antibody-Drug Conjugate Stability in Mouse Skin Homogenate Supernatant Using Liquid Chromatographic-Quadrupole Time-of-Flight Mass Spectrometric Method
Young G. Shin
Favorite
(
M1430-02-09
)
Application of Sequential Window Acquisition of all Theoretical Fragment Ion Spectra Mass Spectrometry (SWATH-MS) for Identification of Tetrapeptide Linker Cleavage Profile of Antibody Drug Conjugate
Young G. Shin
Favorite
(
M1530-02-07
)
Simultaneous Analysis of Antibody-Conjugated Drug(acDrug) and Total Antibody(tAb) for Antibody Drug Conjugate Using Dual Enzyme-Assisted Sample Preparation Followed by LC-MS
Young G. Shin
Favorite
(
M1530-02-08
)
Charge Variant Profiling of Antibody-Drug Conjugate Containing Auristatins Using icIEF-UV-MS
Young G. Shin
Favorite
Shipalana, Hlurile
University of the Free State
(
M1430-01-01
)
Nanocapsules for Combined Delivery of Docetaxel and
Laguncularia Racemosa
Extract Against Oral Cancer Cells In Vitro
Hlurile Shipalana
Favorite
Shi, Wenting
Georgia Institute of Technology
(
T1330-01-02
)
Optimizing Gel Network Architecture for Oxanorbornadiene-Based Degradable Hydrogels
Wenting Shi
Favorite
Shouse, Lauren
Samford University
(
M1030-01-05
)
Evaluating the Immunomodulatory Efficacy of an Ethanolic Spray-Dried Extract of Spirulina
Lauren Shouse
Favorite
Siddhanta, Kasturi
University of Nebraska Medical Center
(
T1030-01-04
)
Development of Polymer-Based miRNA Delivery System for CXCR4 Inhibition and miR155 Inhibition in Target Cells in the Liver to Treat Alcohol-Associated Liver Disease
Kasturi Siddhanta
Favorite
Silva, Kalhari
Custom Biologics
(
T0930-02-08
)
Validation of an Anti-Drug Antibody Assay Against an Oncolytic Virus Immunotherapeutic
Kalhari Silva
Favorite
Sinegra, Andrew
Merck & Co., Inc.
(
M1330-01-01
)
Utility of Small Angle X-Ray Scattering (SAXS) in Process Development, Characterization and Comparability of Lipid Nanoparticles, Liposomes and Fusion Proteins
Andrew Sinegra
Favorite
Singh, Vikas
Eurofins Viracor Biopharma Services
(
M1230-02-08
)
Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab
Vikas Singh
Favorite
Sinha, Garima
Croda Inc.
(
M1130-02-09
)
Alternative Detergents to Triton X-100 for Disrupting Lipid Nanoparticles and Enhancing RNA Encapsulation Quantification in RiboGreen Assay
Garima Sinha
Favorite
Sinko, Balint
Pion Inc.
(
M1130-02-08
)
Conserving Biorelevant Enzymatic Activity during In Vitro Analysis of Biotransformable Drugs
Balint Sinko
Favorite
Sintetas, Ashley
Eurofins Viracor BioPharma Services
(
M1230-02-08
)
Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab
Ashley Sintetas
Favorite
Solomon, Matthew
Merck & Co., Inc.
(
T1430-02-09
)
Overcoming Selectivity Barriers of a Ligand Binding Assay
Matthew Solomon
Favorite
Song, Kent
Sanofi
(
T1130-02-08
)
Evaluation of the MSD S-Plex Neuropanel 1 Multiplex Assay for Neurological Biomarkers
Kent Song
Favorite
Souleyrette, Caroline
University of Tennessee
(
M1430-01-03
)
Enhanced Membrane Composition for Lipid Nanoparticle Vascular Drug Delivery
Caroline Souleyrette
Favorite
(
T1430-01-04
)
Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies
Caroline Souleyrette
Favorite
Stanta, Johannes
Celerion
(
M1030-02-09
)
Advancing Peripheral Blood Mononuclear Cells Isolation for ELISPOT Analysis: Time Is Critical
Johannes Stanta
Favorite
(
M1230-02-09
)
Bringing Unstable Flow Cytometry Assays Closer to the Patient: Case Study of an Ex Vivo CD11b Stimulation Flow Cytometry Assay Collected at External Clinical Site
Johannes Stanta
Favorite
Stark, Jared
KCAS Bio
(
M1530-02-09
)
Development of a High Throughput LC-MS/MS 1.5 Plex Assay for Quantitation of Total Antibody (TAb) and Intact Antibody Drug Conjugate (ADC) Using Immunoprecipitation by Specific Receptor Capture
Jared Stark
Favorite
Steeno, Greg
Pfizer Inc.
(
M1130-02-07
)
Embracing Singlicate Ligand Binding Biomarker Assays: A Case Study Comparing Duplicate vs Singlicate Analysis for the Determination of IL-6, IFN-gamma, and TNF-alpha in Human Sodium Heparin Plasma
Greg Steeno
Favorite
Stein, Andrew
Novartis
(
T1230-02-08
)
Reverse Translational Modeling for Early Benchmarking of Clinically Active Doses from In Vitro Cell Killing and T-Cell Activation Data for BCMAxCD3 T-Cell Engagers
Andrew Stein
Favorite
Stevens, Scott
University of Tennessee
(
M1430-01-03
)
Enhanced Membrane Composition for Lipid Nanoparticle Vascular Drug Delivery
Scott Stevens
Favorite
(
T1430-01-04
)
Long-Term Storage of Targeted Lipid Nanoparticles for Vascular Gene Therapies
Scott Stevens
Favorite
Sun, Li
Merck & Co., Inc.
(
T1130-02-06
)
Using Tasso-M20 Microsampling Device to Support a Clinical PK Study
Li Sun
Favorite
Suryanarayanan, Raj
University of Minnesota
(
T1230-01-05
)
Impact of Excipient Composition on the Stability of Trastuzumab Biosimilars
Raj Suryanarayanan
Favorite
Svilenov, Hristo
Technical University
(
M1230-01-02
)
Additivity of Transfer Free Energies Enables Description of Complex Protein Formulations in Implicit Solvent Molecular Dynamics Simulations
Hristo Svilenov
Favorite
(
M1430-01-05
)
Running at the Verge of Collapse in Lyophilization: What is the Impact of the Edge Vial Effect on Protein Stability and Particle Morphology?
Hristo Svilenov
Favorite
